Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe cost of Wegovy in the UK varies by dose and by provider, and for a legitimate private prescription that includes clinical assessment, the range typically sits somewhere between £150 and £375 per month depending on which strength you're on. That's the honest answer up front. What matters just as much is understanding what sits behind that figure, because two prices that look similar on a comparison site can represent very different things in practice. Wegovy (semaglutide) is a prescription-only medicine licensed for weight management in the UK; a prescriber must assess your suitability before any treatment can be dispensed, so the cost question and the clinical question are inseparable.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a question our prescribers hear most weeks, usually phrased as: "I found it cheaper elsewhere — is it the same thing?" It's a fair question, and the truthful answer is: not necessarily. Headline prices for Wegovy online often reflect only the medicine itself, with consultation fees, prescription charges, delivery costs and any ongoing clinical support billed separately or not offered at all. Add those back in and the gap between providers frequently narrows significantly.
There's also a supply-chain layer worth understanding. Eli Lilly raised Mounjaro's UK list price substantially from September 2025, and Wegovy's pricing has similarly shifted in a market where demand far exceeds NHS capacity. Reported private prices across UK providers have ranged roughly £149 to £375 per month by dose, and you can read a fuller breakdown of how Wegovy doses affect what you pay each month. Those figures come from widely reported coverage of the market and should be treated as a guide rather than a fixed tariff — your actual cost depends on which dose you're taking, since Wegovy is titrated across five steps from 0.25mg up to 2.4mg (and, with the newer 7.2mg pen, potentially further), and lower maintenance doses cost less than higher ones. If you want to understand exactly how many doses come in each Wegovy pen, that can help you make sense of what a monthly supply genuinely covers before you compare prices across providers.
The myth worth correcting first, then, is that cost comparisons are straightforward. They rarely are. The right question isn't "who is cheapest" but "what does this price actually include?"
A quoted monthly price for Wegovy becomes meaningfully more expensive once you add what many providers charge on top. Consultation fees can run from £20 to over £100 depending on the clinic. Prescription charges are sometimes separate again. Delivery, particularly the cold-chain delivery required for injectable medicines, can add a further charge per order. And if you need support between orders (a question about a side effect at the weekend, a review before stepping up your dose) some providers bill for that too or simply don't offer it.
There's also the clinical depth question. Wegovy is a prescription medicine, which means a prescriber is making a judgement about your health. The rigour of that assessment varies. A genuine consultation checks your BMI, your medical history, your current medicines (oral contraceptives, for instance, may need additional contraceptive cover during treatment, something the NHS England guidance on weight-management injections addresses specifically), and flags contraindications. A box-ticking questionnaire is not the same thing, even if it produces a prescription.
It's also worth knowing how many doses a semaglutide pen contains, since this can help you cross-check what a monthly supply actually means in practice, something that's easy to misread when providers quote per-pen versus per-month pricing.
At nume, one transparent price covers your consultation, your prescription, your medicine, and free next-working-day delivery by DPD. There are no separate consultation fees, no add-on prescription charges, no delivery surcharges. Aftercare is included, seven days a week, with a real clinical re-review before every repeat, not an automated refill. Every consultation is personally read by a GPhC-registered Independent Prescriber, the same day you submit it. Our pharmacy is registered with the GPhC (registration number 9012878, verifiable on the GPhC register), and all medicines come through the licensed UK supply chain.
We don't position ourselves as the lowest price in the market. We entered this deliberately. What we offer instead is a service where the price you see is the price you pay, clinical oversight is genuine, and your medicine arrives in tracked, plain packaging the next working day if you order before 12pm. Current treatment pricing is shown on our weight-loss treatments page. We don't run discount codes or promotional offers, for a prescription medicine, that's not a limitation; it's a deliberate stance on safety.
You can also compare the broader cost picture for Wegovy in the UK if you want more context before starting a consultation.
The MHRA has warned publicly about counterfeit weight-loss pens being sold online and via social media. Fake pens have contained insulin rather than semaglutide, and enforcement in 2025 resulted in the seizure of around 20 million doses of illegally traded weight-loss medicines worth approximately £45 million. A price substantially below the market range is one of the clearest red flags that a product may not be what it claims. Others include sellers who supply these medicines without a prescription or clinical assessment, and anyone offering discount vouchers for prescription-only medicines. You can report suspect sellers directly via the MHRA's Yellow Card scheme.
For a medicine that works by titrating gradually through several dose levels over months, the relationship with your prescriber matters as much as the medicine itself. Dose increases should be clinically reviewed, not automatic. Side effects should be monitored. If you're considering Wegovy, the full cost breakdown is one part of the picture, the clinical pathway is another. A genuine, well-structured consultation is where both conversations start.
If you'd like to explore whether Wegovy is clinically suitable for you, start your free consultation with our prescribers today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.